Journals / Turkish Journal of Gastroenterology / 2013 / Cilt: 24 - Sayı: 3

SCP2, insan hepatositlerinde HMGCR ve CYP7A1’i regüle ederek safra litojenisitesini arttırır

Increased bile lithogenicity by SCP2 via HMGCR and CYP7A1 regulation in human hepatocytes

Pages
241–250
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Likely influences cholesterol metabolism and bile lithogenicity of human liver cells by regulating the expression of HMGCR and CYP7A1

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aims: Lithogenic bile is a major cause of cholesterol gallstones, and hypersecretion of biliary cholesterol is believed to be an important cause of lithogenic bile.
📊
Key Findings & Data:Sterol carrier protein 2 plays a key role in cholesterol trafficking and may regulate lipid metabolism in hepatocytes.
💡
Conclusion & Impact:Likely influences cholesterol metabolism and bile lithogenicity of human liver cells by regulating the expression of HMGCR and CYP7A1
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aims: Lithogenic bile is a major cause of cholesterol gallstones, and hypersecretion of biliary cholesterol is believed to be an important cause of lithogenic bile. Sterol carrier protein 2 plays a key role in cholesterol trafficking and may regulate lipid metabolism in hepatocytes. Materials and Methods: Human sterol carrier protein 2 cDNA was cloned and shRNAs against sterol carrier protein 2 were synthesized. Sterol carrier protein 2-modified hepatocyte models were then set up using adenoviral vectors to study its regulatory function in lipid metabolism. Following overexpression and knockdown of sterol carrier protein 2, HMGCR and CYP7A1 expression as well as the secretion of bile lipids were studied in hepatocytes. Results: The expression of HMGCR was enhanced by sterol carrier protein 2 overexpression and downregulated by sterol carrier protein 2 knockdown. The concentration of cholesterol in the supernatant was elevated under sterol carrier protein 2 overexpression and decreased under sterol carrier protein 2 downregulation. Although sterol carrier protein 2 overexpression could repress the expression of CYP7A1, no changes were noted in total bile acid concentration. Thus, the expression of sterol carrier protein 2 could influence bile lithogenicity in the sterol carri- er protein 2-modified hepatocyte models. Conclusions: Sterol carrier protein 2 may function as a moderator of HMGCR in human hepatocytes. Likely influences cholesterol metabolism and bile lithogenicity of human liver cells by regulating the expression of HMGCR and CYP7A1

Özet

Giriş ve Amaç: Litojenik safra kolesterol taşlarının en önemli nedenidir ve safrada kolesterolün aşırı salgılanmasının litojenik saf- ranın önemli bir nedeni olduğuna inanılmaktadır. Sterol taşıyıcı protein 2 kolestorol taşınmasında anahtar role sahiptir ve hepa- tositlerde lipid metaboizmasını regüle eder. Gereç ve Yöntem: İnsan sterol taşıyıcı protein 2 cDNA klonlanmış ve buna karşı shRNAs sentezlenmiştir, ertesinde adenovirüs vektörler ile oluşturulan sterol taşıyıcı protein 2-modifiye hepatosit modelleri kulla- nılarak regülatuvar fonksiyonları araştırılmıştır. Sterol taşıyıcı protein 2'nin aşırı ekspresyonunda ve silinmesinde, HMGCR ve CYP7A1 ekspresyonları ve hepatositlerden safra lipidlerinin sentezi incelenmiştir. Bulgular: HMGCR ekspresyonu, sterol taşıyıcı protein 2 aşırı ekspresyonu ile artmış, silinmesi ile azaldığı tespit edilmiştir. Ayrıca sterol taşıyıcı protein 2 aşırı ekspresyonunda supernatan içindeki kolesterol konsantrasyonun arttığı, baskılanması halinde azaldığı bulundu. Sterol taşıyıcı protein 2 aşırı eks- presyonu CYP7A1 ekspresyonunu baskılamasına rağmen total safra asidi konsantrasyonunda değişiklik tespit edilmedi. Sterol ta- şıyıcı protein 2'nin, modifiye hepatosit modellerinde safra litojenisitesini etkileyebildiği bulundu. Sonuç: Sterol taşıyıcı protein 2 hepatositlerde HMGCR'ın modülatörü olabilir. Sterol taşıyıcı protein 2 kolesterol metabolizmasını etkileyebilir ve hepatositlerdeki HMGCR ve CYP7A1 ekspresyonunu etkileyerek safranın litojenistesini değiştirebilir

🔖

Cite This Article

YUNFENG, C., ZHONGLIAN, L., ERPENG, Z., JU, Z., NAIQIANG, C. (2013). SCP2, insan hepatositlerinde HMGCR ve CYP7A1’i regüle ederek safra litojenisitesini arttırır. Turkish Journal of Gastroenterology, Cilt: 24 - Sayı: 3, 241–250. https://ajindex.com/articles/409609

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Lammert F, Sauerbruch T. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol 2005;2:423-33
  2. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006;368:230-39
  3. Marschall HU, Einarsson C. Gallstone disease. J Intern Med 2007;261:529-42
  4. Venneman NG, van Erpecum KJ. Pathogenesis of gallstones. Gastroenterol Clin North Am 2010;39:171-83
  5. Wirtz KW. Phospholipid transfer proteins revisited. Biochem J 1997;324:353-60
  6. Tsuneoka M, Yamamoto A, Fujiki Y, Tashiro Y. Nonspecific lipid transfer protein (sterol carrier protein-2) is located in rat liver peroxisomes. J Biochem 1988;104:560-4
  7. Keller GA, Scallen TJ, Clarke D, et al. Subcellular localization of sterol carrier protein-2 in rat hepatocytes: its primary localization to peroxisomes. J Cell Biol 1989;108:1353-61
  8. Schroeder F, Butko P, Hapala I, Scallen TJ. Intermembrane cholesterol transfer: role of sterol carrier proteins and phosphatidylserine. Lipids 1990;25:669-74
  9. Kraemer R, Pomerantz KB, Kesav S, et al. holesterol enrichment enhances expression of sterol carrier protein 2:implications for its function in intracellular cholesterol trafficking. J Lipid Res 1995;36:2630-8
  10. Puglielli L, Rigotti A, Amigo L, et al. Modulation of intrahepatic cholesterol trafficking: evidence by in vivo antisense treatment for the involvement of sterol carrier protein 2 in newly synthesized cholesterol transport into rat bile. Biochem J 1996;317:681-7
  11. Noland BJ, Arebalo RE, Hansbury E, Scallen TJ. Purification and properties of sterol carrier protein-2. J Biol Chem 1980;255:4282-9
  12. Amigo L, Zanlungo S, Miquel JF, et al. Hepatic overexpression of sterol carrier protein-2 inhibits VLDL production and reciprocally enhances biliary lipid secretion. J Lipid Res 2003;44:399-407
  13. Mukherji M, Kershaw NJ, Schofield CJ, et al. Utilization of sterol carrier protein 2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal alpha oxidation of phytanic acid. Chem Biol 2002;9:597-605
  14. Seltman H, Diven W, Rizk M, et al. Regulation of bile-acid synthesis. Role of sterol carrier protein 2 in the biosynthesis of 7 alpha-hydroxycholesterol. Biochem J 1985;230:19- 24
  15. Lidstrom B, Wikvall K. The role of sterol carrier protein 2 and other hepatic lipid-binding proteins in bile-acid biosynthesis. Biochem J 1986;238:879-8
  16. Stolowich NJ, Petrescu AD, Huang H, et al. Sterol carrier protein 2: structure reveals function. Ce